Holocene Advisors, LP Edwards Lifesciences Corp Transaction History

Holocene Advisors, LP

$40.7 Billion
Q3 2025

A detailed history of Holocene Advisors, LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Holocene Advisors, LP holds 4,746,694 shares of EW stock, worth $410 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

4,746,694

Previous 4,703,977 0.91%

Holding current value

$410 Million

Previous $368 Million 0.34%

% of portfolio

0.91%

Previous 0.97%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$73.75 - $81.83 $3.15 Million - $3.5 Million	42,717 Added 0.91%	4,746,694 $369 Million
Q2 2025 Aug 14, 2025	BUY	$67.07 - $78.22 $82.1 Million - $95.7 Million	1,223,460 Added 35.15%	4,703,977 $368 Million
Q1 2025 May 15, 2025	BUY	$67.95 - $76.19 $72.7 Million - $81.6 Million	1,070,432 Added 44.41%	3,480,517 $252 Million
Q4 2024 Feb 14, 2025	SELL	$64.54 - $75.92 $25.6 Million - $30.2 Million	-397,382 Reduced 14.15%	2,410,085 $178 Million
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $3.24 Million - $5.08 Million	-54,194 Reduced 1.89%	2,807,467 $185 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $45.3 Million - $50.6 Million	-536,990 Reduced 15.8%	2,861,661 $264 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $183 Million - $241 Million	2,517,704 Added 285.8%	3,398,651 $325 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $15.8 Million - $19.9 Million	255,869 Added 40.93%	880,947 $67.2 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $131 Million - $177 Million	-1,893,208 Reduced 75.18%	625,078 $43.3 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $23.8 Million - $27.6 Million	-292,711 Reduced 10.41%	2,518,286 $238 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $13.3 Million - $15.1 Million	178,802 Added 6.79%	2,810,997 $233 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $17 Million - $21.7 Million	-248,443 Reduced 8.62%	2,632,195 $196 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $80.4 Million - $105 Million	975,520 Added 51.21%	2,880,638 $238 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $2.63 Million - $3.9 Million	-30,428 Reduced 1.57%	1,905,118 $181 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $2.42 Million - $3.05 Million	-23,740 Reduced 1.21%	1,935,546 $228 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $113 Million - $139 Million	1,060,575 Added 118.01%	1,959,286 $254 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $15.1 Million - $18 Million	146,476 Added 19.47%	898,711 $102 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $63.1 Million - $78.8 Million	752,235 New	752,235 $77.9 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $20.1 Million - $23.2 Million	-255,866 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $63.7 Million - $81.1 Million	-889,043 Reduced 77.65%	255,866 $23.3 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $23.8 Million - $31 Million	-354,120 Reduced 23.62%	1,144,909 $91.4 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $62.1 Million - $83 Million	1,078,610 Added 256.56%	1,499,029 $104 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $22 Million - $34.1 Million	420,419 New	420,419 $79.3 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $22.7 Million - $26 Million	-317,083 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $19.5 Million - $23.9 Million	317,083 New	317,083 $69.7 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $105,211 - $129,082	-2,267 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $103,601 - $131,554	2,267 New	2,267 $395,000
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $313,437 - $399,908	-8,428 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $284,782 - $331,978	8,428	8,428 $950,000

Others Institutions Holding EW

# of Institutions

1,457

Shares Held

468M

Call Options Held

3.49M

Put Options Held

4.09M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Account

Holocene Advisors, LP Edwards Lifesciences Corp Transaction History